Arrowstreet Capital Limited Partnership Sells 551,791 Shares of Nutrien Ltd. $NTR

Arrowstreet Capital Limited Partnership decreased its position in shares of Nutrien Ltd. (NYSE:NTR) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,669,590 shares of the company’s stock after selling 551,791 shares during the period. Arrowstreet Capital Limited Partnership owned 2.84% of Nutrien worth $843,726,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Swiss Life Asset Management Ltd grew its holdings in Nutrien by 23.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 79,770 shares of the company’s stock valued at $4,691,000 after buying an additional 15,230 shares in the last quarter. Van ECK Associates Corp grew its holdings in Nutrien by 1.4% during the 3rd quarter. Van ECK Associates Corp now owns 1,854,650 shares of the company’s stock valued at $108,901,000 after buying an additional 25,588 shares in the last quarter. MH & Associates Securities Management Corp ADV purchased a new stake in Nutrien during the 4th quarter valued at approximately $1,967,000. Hudson Bay Capital Management LP grew its holdings in Nutrien by 190.3% during the 3rd quarter. Hudson Bay Capital Management LP now owns 116,312 shares of the company’s stock valued at $6,829,000 after buying an additional 76,244 shares in the last quarter. Finally, Black Creek Investment Management Inc. grew its holdings in Nutrien by 57.3% during the 3rd quarter. Black Creek Investment Management Inc. now owns 2,367,244 shares of the company’s stock valued at $139,050,000 after buying an additional 862,487 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Up 3.2%

NYSE:NTR opened at $67.65 on Friday. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The company has a market cap of $32.47 billion, a price-to-earnings ratio of 13.78, a price-to-earnings-growth ratio of 0.62 and a beta of 0.60. The stock has a fifty day simple moving average of $71.34 and a 200-day simple moving average of $69.17. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR) last released its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same period last year, the company earned $0.11 earnings per share. The business’s revenue for the quarter was up 18.5% compared to the same quarter last year. Analysts anticipate that Nutrien Ltd. will post 5.45 EPS for the current year.

Nutrien Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Tuesday, June 30th. Nutrien’s dividend payout ratio (DPR) is 44.81%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on NTR. Raymond James Financial raised shares of Nutrien from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $74.00 to $90.00 in a report on Tuesday, May 5th. UBS Group cut their price objective on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a report on Monday, May 11th. Oppenheimer increased their price objective on shares of Nutrien from $80.00 to $82.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. TD Securities reaffirmed a “buy” rating on shares of Nutrien in a report on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their price objective on shares of Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, April 7th. Eleven equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $81.71.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.